White House deal targets lower US drug prices via $19.6B infusion
White House deal with mid-size drugmakers includes a $19.6B infusion into US plants aimed at lowering drug prices.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.